Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
SchooLinks Recognized Among America's Best Startup Employers by Forbes and Inc.
-
Wolters Kluwer 2024 Annual General Meeting of Shareholders adopts all resolutions
-
Gilat Reports First Quarter 2024 Results
-
Celcuity Inc. Schedules Release of First Quarter 2024 Financial Results and Webcast/Conference Call
-
Vertex Announces First Quarter 2024 Financial Results
-
Olema Oncology Announces New Clinical Data for Palazestrant in Combination with Ribociclib to be Presented at the 2024 ESMO Breast Cancer Annual Congress
-
MegaWatt Metals Provides Corporate Update, Including Advancing Clean-Energy Focus Through Agreement to Acquire Uranium Property
-
Black Diamond Group Limited Announces Renewal of Normal Course Issuer Bid
-
Brink's Announces Strong First-Quarter Results and Affirms Full Year Guidance
-
Sprott Announces First Quarter 2024 Results
-
StateHouse Announces Receipt of Failure to File Cease Trade Order
-
Brink's Announces Strong First-Quarter Results and Affirms Full Year Guidance
-
CanLift Celebrates 15 Years of Business in Ontario
-
SpringWorks Therapeutics to Participate in the BofA Securities 2024 Health Care Conference
-
Aura Biosciences to Participate in Upcoming Investor Conferences
-
Kamada Reports Strong First Quarter 2024 Financial Results with Year-Over-Year Top-Line Growth of 23% and a 96% Increase in Profitability; Raises Full-Year Financial Guidance
-
Cingulate Reports First Quarter 2024 Financial ResultsĀ and Provides Clinical and Business Update
-
Brunswick Exploration Drills 93.45 Meters at 1.55% Li2O at MR-6
-
Standard Uranium Begins Inaugural Drill Program at Canary Project, Eastern Athabasca Basin
-
Microbix Schedules Release of Results for Q2 Fiscal 2024
-
Hain Celestial Reports Fiscal Third Quarter 2024 Financial Results
-
Amicus Therapeutics to Present at the Bank of America 2024 Health Care Conference
-
Bio-Path Holdings to Announce First Quarter 2024 Financial Results on May 15, 2024
-
R1 RCM Reports First Quarter 2024 Results
-
EyePoint Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Corporate Developments
-
Dragonfly Energy Named Business of the Year at Nevada Business Awards
-
Cartesian Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
-
Sage launches two new integrated suites in Canada and the UK to help Accountants and Small Businesses drive growth
-
Avadel Pharmaceuticals Provides Corporate Update and Reports First Quarter 2024 Financial Results
-
Arbor Biotechnologies Announces Acquisition of Serendipity
-
Beasley Broadcast Group Reports First Quarter Revenue of $54.4 Million
-
PolyPid Provides Corporate Update and Reports First Quarter 2024 Financial Results
-
Zevra Therapeutics Reports First Quarter 2024 Financial Results and Corporate Updates
-
GDS to Report First Quarter 2024 Financial Results Before the Open of the U.S. Market on May 22, 2024
-
OKYO Pharma Announces Participation in May 2024 Investor Conferences
-
PolyPid Provides Corporate Update and Reports First Quarter 2024 Financial Results
-
Inception Growth Acquisition Limited Announces Additional Contribution to Trust Account to Extend Business Combination Period
-
Chemomab Therapeutics Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule
-
Village Farms International Reports Strong Q1/24 Results
-
Multi Ways Holdings Expands Fleet with the Acquisition of 16 New Crawler Cranes
-
Axsome Therapeutics to Present at Upcoming Investor Conferences
-
Akero Therapeutics to Present at the BofA Securities 2024 Health Care Conference
-
Stella-Jones Announces First Quarter Results
-
Mayfair Gold Provides Update on Fenn-Gib Gold Project
-
Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2024 Financial Results
-
EcoSafi announces the first issuance of carbon credits in Africa under high-integrity Gold Standard MECD methodology
-
Gen II Announces The Rebranding of its Portal to Sensr Portal
-
Editas Medicine Announces First Quarter 2024 Results and Business Updates
-
C4 Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
-
Kaltura Announces Financial Results for First Quarter 2024

